Reaction
Progressive Multiple Sclerosis reporting signals
As of the last recalculation, Progressive Multiple Sclerosis appears in 1,156 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is INTERFERON BETA-1B (PRR 39.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Interferon Beta-1B | 41 | 39.9 | 40.0 |
| Umeclidinium | 19 | 38.8 | 38.9 |
| Interferon Beta-1A | 303 | 37.9 | 38.0 |
| Glatiramer Acetate | 102 | 33.6 | 33.7 |
| Dalfampridine | 116 | 32.3 | 32.3 |
| Natalizumab | 233 | 28.7 | 28.7 |
| Baclofen | 112 | 25.8 | 25.9 |
| Teriflunomide | 60 | 25.1 | 25.2 |
| Ocrelizumab | 72 | 22.2 | 22.3 |
| Dimethyl Fumarate | 126 | 20.6 | 20.6 |
| Fingolimod Hcl | 90 | 20.2 | 20.3 |
| Diroximel Fumarate | 13 | 19.9 | 19.9 |
| Ofatumumab | 28 | 15.5 | 15.5 |
| Amantadine | 13 | 15.3 | 15.3 |
| Ozanimod Hydrochloride | 7 | 15.3 | 15.3 |
| Ticagrelor | 22 | 12.6 | 12.6 |
| Tizanidine | 15 | 11.5 | 11.5 |
| Siponimod | 5 | 10.1 | 10.1 |
| Peginterferon Beta-1A | 7 | 9.7 | 9.7 |